Kee Woong Kwon

10PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsInnate immunityGene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 06, 2025
Mycobacterium tuberculosis-specific T cells restrain anti-cancer drug-induced neutrophilic lung inflammation in tuberculosis.

Kee Woong Kwon, Tae Gun Kang, Jii Bum Lee

|Mar 08, 2024
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice.

Kee Woong Kwon, Han-Gyu Choi, Kwang Sung Kim

|May 14, 2023
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against <i>Mycobacterium tuberculosis</i> Infection.

Kee Woong Kwon, Tae Gun Kang, Ara Lee

|Aug 30, 2022
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.

Lee-Han Kim, Soon Myung Kang, Jake Whang

|Jun 07, 2022
Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx.

Tae Gun Kang, Kee Woong Kwon, Kyungsoo Kim

|May 02, 2022
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against <i>Mycobacterium avium</i> infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.

Ju Mi Lee, Jiyun Park, Steven G Reed

Pageof 2

Frequent Collaborators

9 joint publications

Sung Jae Shin

3 joint publications

Sang-Jun Ha

3 joint publications

Jumi Lee

3 joint publications

Lee-Han Kim